CDI‑988 is the first oral antiviral drug candidate being developed for prevention and treatment of norovirus infectionsCompany to present Phase 1 ...

There are currently no approved vaccines or treatments for norovirus infection Cocrystal’s CDI-988 is the first antiviral for the potential prevention and treatment of viral gastroenteritis caused by ...

Cocrystal Pharma, Inc. (NASDAQ:COCP) is developing CDI-988 as a prophylaxis and treatment for norovirus, coronavirus, and other viral infections. The company recently presented results from the Phase ...

Norovirus can strike suddenly, leaving you feeling nauseous and exhausted. Here's what to know if it hits you this winter.

Subject enrollment expected to begin in Q1 2026 CDI-988 is the first oral broad-spectrum antiviral drug candidate for potential prevention of norovirus outbreaks and treatment of acute viral ...

Add Yahoo as a preferred source to see more of our stories on Google. Emergency rooms and urgent cares are seeing an increase of people being diagnosed with norovirus. This highly contagious virus is ...

Norovirus, the infamous "winter vomiting disease," is surging again across the United States. Norovirus is a highly contagious stomach bug that causes sudden, often violent bouts of diarrhea and ...